» Authors » Olivier Loudig

Olivier Loudig

Explore the profile of Olivier Loudig including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 671
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Mitchell M, Ma J, Carter C, Loudig O
Cancers (Basel) . 2022 Jul; 14(14). PMID: 35884411
Although diagnostic and therapeutic treatments of cancer have tremendously improved over the past two decades, the indolent nature of its symptoms has made early detection challenging. Thus, inter-disciplinary (genomic, transcriptomic,...
12.
Wu C, Zhou S, Mitchell M, Hou C, Byers S, Loudig O, et al.
Anal Bioanal Chem . 2022 Feb; 414(8):2585-2595. PMID: 35181835
It has been a challenge to analyze minute amounts of proteomic samples in a facile and robust manner. Herein, we developed a quantitative proteomics workflow by integrating suspension trapping (S-Trap)-based...
13.
Rohan T, Ginsberg M, Wang Y, Couch F, Feigelson H, Greenlee R, et al.
BMJ Open . 2021 Oct; 11(10):e053397. PMID: 34702732
Introduction: Ductal carcinoma in situ (DCIS) of the breast is a non-obligate precursor of invasive breast cancer (IBC). Many DCIS patients are either undertreated or overtreated. The overarching goal of...
14.
Valdebenito S, Malik S, Luu R, Loudig O, Mitchell M, Okafo G, et al.
Sci Rep . 2021 Jul; 11(1):14556. PMID: 34267246
Cell-to-cell communication is essential for the development and proper function of multicellular systems. We and others demonstrated that tunneling nanotubes (TNT) proliferate in several pathological conditions such as HIV, cancer,...
15.
Sharif G, Campbell M, Nasir A, Sengupta S, Graham G, Kushner M, et al.
Cancer Res . 2021 Jun; 81(16):4230-4241. PMID: 34135000
AIB1Δ4 is an N-terminally truncated isoform of the oncogene amplified in breast cancer 1 (AIB1) with increased expression in high-grade human ductal carcinoma (DCIS). However, the role of AIB1Δ4 in...
16.
Mitchell M, Ben-Dov I, Liu C, Ye K, Chow K, Kramer Y, et al.
J Extracell Vesicles . 2021 Jun; 10(8):e12110. PMID: 34122779
Circulating nucleic acids, encapsulated within small extracellular vesicles (EVs), provide a remote cellular snapshot of biomarkers derived from diseased tissues, however selective isolation is critical. Current laboratory-based purification techniques rely...
17.
Fontelles C, da Cruz R, Gonsiewski A, Barin E, Tekmen V, Jin L, et al.
Sci Rep . 2021 Apr; 11(1):7317. PMID: 33795711
We previously showed that environmentally-induced epigenetic inheritance of cancer occurs in rodent models. For instance, we reported that paternal consumption of an obesity-inducing diet (OID) increased breast cancer susceptibility in...
18.
Figueroa J, Gierach G, Duggan M, Fan S, Pfeiffer R, Wang Y, et al.
Breast Cancer Res . 2021 Mar; 23(1):34. PMID: 33736682
Background: Among women diagnosed with invasive breast cancer, 30% have a prior diagnosis of benign breast disease (BBD). Thus, it is important to identify factors among BBD patients that elevate...
19.
Cohen P, Loudig O, Liu C, Albanese J, Fineberg S
Front Pharmacol . 2019 Jun; 10:524. PMID: 31191299
We assessed mRNA and protein expression levels of the ZN217 oncogene in 17 clinical FFPE ER-positive invasive breast cancer specimens with known (low or high) Oncotype DX Recurrence Scores. This...
20.
Rohan T, Wang T, Weinmann S, Wang Y, Lin J, Ginsberg M, et al.
Cancer Res . 2019 Feb; 79(7):1705-1713. PMID: 30760517
Dysregulation of miRNA expression may influence breast cancer progression, and experimental evidence suggests that miRNA silencing might suppress breast cancer metastasis. However, the relationship between miRNA and metastasis must be...